Inspire Medical Systems, Inc. (INSP)
USD 186.97
(-1.96%)
USD 186.97
(-1.96%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 24.65 Million | 11.56 Million | -20.11 Million | -53.04 Million | -32.84 Million | -18.69 Million |
| Net Income | -21.15 Million | -44.88 Million | -42.04 Million | -57.2 Million | -33.24 Million | -21.82 Million |
| Depreciation & Amortization | 2.84 Million | 1.85 Million | 1.21 Million | 840 Thousand | 495 Thousand | 393 Thousand |
| Deferred income taxes | -2.46 Million | - | 14 Thousand | -22 Thousand | -983 Thousand | -53 Thousand |
| Stock-based compensation | 82.82 Million | 51.97 Million | 26.17 Million | 12.81 Million | 6.19 Million | 1.21 Million |
| Change in working capital | -40.78 Million | 1.81 Million | -6.85 Million | -10.87 Million | -6.57 Million | 861 Thousand |
| Other non-cash items | 3.74 Million | 812 Thousand | 1.36 Million | 1.4 Million | 1.26 Million | 714 Thousand |
| Investing Cash Flow | -294.82 Million | -19.59 Million | 29.13 Million | 86.62 Million | -43.55 Million | -83.38 Million |
| Investments in PPE | -23.62 Million | -9.09 Million | -4.66 Million | -2.45 Million | -2.73 Million | -250 Thousand |
| Acquisitions | 271.19 Million | - | -33.8 Million | -89.08 Million | 40.82 Million | - |
| Investment purchases | -281.43 Million | -10.5 Million | -9.99 Million | -52.72 Million | -178.07 Million | -115.48 Million |
| Sales/Maturities of investments | 10.24 Million | - | 43.8 Million | 141.8 Million | 137.25 Million | 32.34 Million |
| Other Investing Activities | -271.19 Million | -10.5 Million | 33.8 Million | 89.08 Million | -40.82 Million | -83.13 Million |
| Financing Cash Flow | 13.95 Million | 235.07 Million | 14.94 Million | 134.06 Million | 1.96 Million | 190.38 Million |
| Debt repayment | - | -24.5 Million | - | - | - | -8 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -17.15 Million | -43 Thousand | 3.47 Million | 2.36 Million | 1.35 Million | - |
| Common Stock Issuance | 31.1 Million | 259.62 Million | 14.94 Million | 134.06 Million | 2.49 Million | 181.82 Million |
| Other Financing Activities | 31.1 Million | -43 Thousand | -3.47 Million | 134.06 Million | 1.96 Million | 8.55 Million |
| Accounts receivables | -30.21 Million | -27.01 Million | -9.24 Million | -11.84 Million | -6.48 Million | -2.83 Million |
| Accounts payables | 9.29 Million | 14.35 Million | 4.77 Million | 2.04 Million | 1.03 Million | 439 Thousand |
| Inventory | -21.99 Million | 5.34 Million | -8.75 Million | -2.64 Million | -3.16 Million | 1 Million |
| Other working capital | 42.92 Million | 9.12 Million | 6.36 Million | 1.56 Million | 2.03 Million | 2.25 Million |
| Cash at beginning of period | 441.59 Million | 214.46 Million | 190.51 Million | 22.86 Million | 97.28 Million | 8.95 Million |
| Cash at end of period | 185.53 Million | 441.59 Million | 214.46 Million | 190.51 Million | 22.86 Million | 97.28 Million |
| Capital Expenditure | -23.62 Million | -9.09 Million | -4.66 Million | -2.45 Million | -2.73 Million | -250 Thousand |
| Effect of forex changes on cash | 164 Thousand | 75 Thousand | -19 Thousand | 11 Thousand | 13 Thousand | 33 Thousand |
| Net cash flow / Change in cash | -256.05 Million | 227.12 Million | 23.94 Million | 167.65 Million | -74.42 Million | 88.33 Million |
| Free Cash Flow | 1.02 Million | 2.47 Million | -24.78 Million | -55.5 Million | -35.58 Million | -18.94 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 18.49 Million | 9.79 Million | -10 Million | -21.15 Million | 14.76 Million | -8.54 Million |
| Depreciation & Amortization | 1.85 Million | 1.38 Million | 839 Thousand | 2.84 Million | 817 Thousand | 777 Thousand |
| Deferred income taxes | - | - | - | -2.46 Million | -2.46 Million | -6.17 Million |
| Stock-based compensation | 28.22 Million | 32.32 Million | 26.32 Million | 82.47 Million | 22.84 Million | 19.82 Million |
| Change in working capital | 46.49 Million | -41.54 Million | -4.95 Million | -40.78 Million | -19.9 Million | -9.3 Million |
| Other non-cash items | -42.78 Million | 59.38 Million | 17.22 Million | 3.74 Million | 1.21 Million | 7.04 Million |
| Investing Cash Flow | -102.96 Million | 5.62 Million | -19.53 Million | -294.82 Million | -151.72 Million | -144.24 Million |
| Investments in PPE | -8 Million | -12.39 Million | -11.69 Million | -23.62 Million | -8.03 Million | -6.98 Million |
| Acquisitions | - | - | - | 271.19 Million | 143.69 Million | - |
| Investment purchases | -225.5 Million | -56.29 Million | -55.73 Million | -281.43 Million | -143.93 Million | -137.25 Million |
| Sales/Maturities of investments | 130.54 Million | 74.3 Million | 47.9 Million | 10.24 Million | 246 Thousand | - |
| Other Investing Activities | - | 18.01 Million | -7.83 Million | -271.19 Million | -143.69 Million | -137.25 Million |
| Financing Cash Flow | 9.89 Million | 7.08 Million | 768 Thousand | 13.95 Million | -10.11 Million | 3.5 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | -5.88 Million | -5.88 Million | - | - | - | - |
| Common Stock Repurchased | 8.14 Million | -1.86 Million | -2.84 Million | -17.15 Million | -13.92 Million | -516 Thousand |
| Common Stock Issuance | -12.56 Million | 8.94 Million | 3.61 Million | 31.1 Million | 3.81 Million | 4.01 Million |
| Other Financing Activities | 20.19 Million | -1.86 Million | -2.84 Million | 31.1 Million | 3.81 Million | 4.01 Million |
| Accounts receivables | -9.9 Million | -7.71 Million | 18.96 Million | -30.21 Million | -18.63 Million | -8.47 Million |
| Accounts payables | 1.64 Million | -8.56 Million | 3.55 Million | 9.29 Million | -1.77 Million | -707 Thousand |
| Inventory | -8.4 Million | -10.05 Million | -15.08 Million | -21.99 Million | -7.77 Million | -5.27 Million |
| Other working capital | 27.59 Million | -15.21 Million | -12.38 Million | 42.92 Million | 8.27 Million | 5.15 Million |
| Cash at beginning of period | 188.03 Million | 175.41 Million | 185.53 Million | 441.59 Million | 329.89 Million | 467.05 Million |
| Cash at end of period | 147.51 Million | 188.03 Million | 175.41 Million | 185.53 Million | 185.53 Million | 329.89 Million |
| Capital Expenditure | -8 Million | -12.39 Million | -11.69 Million | -23.62 Million | -8.03 Million | -6.98 Million |
| Effect of forex changes on cash | 272 Thousand | -10 Thousand | -214 Thousand | 164 Thousand | 211 Thousand | -51 Thousand |
| Net cash flow / Change in cash | -40.52 Million | 12.61 Million | -10.12 Million | -256.05 Million | -144.36 Million | -137.15 Million |
| Free Cash Flow | 44.27 Million | -12.47 Million | -2.83 Million | 1.02 Million | 9.23 Million | -3.35 Million |
DLR-PK
8044
0030
RAUTE
005940
IGE